Skip to main content
. Author manuscript; available in PMC: 2022 Feb 17.
Published in final edited form as: Cell Rep. 2021 Jun 29;35(13):109301. doi: 10.1016/j.celrep.2021.109301

Figure 3. 1 week of hepatic GABA-transaminase knockdown improves insulin sensitivity assessed by hyperinsulinemic euglycemic clamp.

Figure 3.

High-fat-diet-induced obese mice received 1 week of injections with a GABA-T targeted or scramble control ASO (12.5 mg/kg i.p. twice weekly) before hyperinsulinemic euglycemic clamps were performed.

(A) Body weight the day of clamp procedures.

(B and C) Blood glucose concentrations (B) and glucose infusion rate during the clamps (C).

(D) Serum insulin concentrations before insulin infusion (basal) and during the clamp.

(E and F) Endogenous glucose appearance (Ra) (E) and glucose disappearance (Rd) (F) before insulin infusion (basal) and during the clamp.

(G) Tissue specific 14C-2-deoxyglucose uptake (PR, perirenal adipose tissue; WAT, white adipose tissue).

Number below bar denotes n per group. All data are presented as mean ± SEM.